Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gutman

Showing results (461-470 of 500) with videos related to

Pageof 50
Sort By:
Blood Advances|October 25, 2019
Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemiaAmanda C Winters, Jonathan A Gutman, Enkhtsetseg Purev, et al.
Molecular Psychiatry|July 22, 1998
Further support for an association between a polymorphic CAG repeat in the hKCa3 gene and schizophreniaT Bowen, C A Guy, N Craddock, et al.
Molecular Cancer Research : MCR|September 25, 2019
Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II ExpressionSanjay Chandrasekaran, Maiko Sasaki, Christopher D Scharer, et al.
Open Forum Infectious Diseases|February 12, 2021
Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal AgentsMatthew A Miller, Kyle C Molina, Jonathan A Gutman, et al.
Nature Communications|December 16, 2016
Heritability of the shape of subcortical brain structures in the general populationGennady V Roshchupkin, Boris A Gutman, Meike W Vernooij, et al.
The Lancet. Haematology|June 29, 2019
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trialBrenda M Sandmaier, Brian Kornblit, Barry E Storer, et al.
Haematologica|April 13, 2023
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemiaJonathan A Gutman, Amanda Winters, Andrew Kent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2013
Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional classW Caleb Rutledge, Jun Kong, Jingjing Gao, et al.
Journal of Neuropathology and Experimental Neurology|January 24, 2023
The status of digital pathology and associated infrastructure within Alzheimer's Disease CentersRebeca Scalco, Yamah Hamsafar, Charles L White, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 4, 2014
Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseasesSandeep Chhabra, Shih Chieh Chang, Hai M Nguyen, et al.
Pageof 50

Showing results (461-470 of 500) with videos related to

Sort By:
Pageof 50
Blood Advances|October 25, 2019
Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemiaAmanda C Winters, Jonathan A Gutman, Enkhtsetseg Purev, et al.
Molecular Psychiatry|July 22, 1998
Further support for an association between a polymorphic CAG repeat in the hKCa3 gene and schizophreniaT Bowen, C A Guy, N Craddock, et al.
Molecular Cancer Research : MCR|September 25, 2019
Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II ExpressionSanjay Chandrasekaran, Maiko Sasaki, Christopher D Scharer, et al.
Open Forum Infectious Diseases|February 12, 2021
Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal AgentsMatthew A Miller, Kyle C Molina, Jonathan A Gutman, et al.
Nature Communications|December 16, 2016
Heritability of the shape of subcortical brain structures in the general populationGennady V Roshchupkin, Boris A Gutman, Meike W Vernooij, et al.
The Lancet. Haematology|June 29, 2019
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trialBrenda M Sandmaier, Brian Kornblit, Barry E Storer, et al.
Haematologica|April 13, 2023
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemiaJonathan A Gutman, Amanda Winters, Andrew Kent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2013
Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional classW Caleb Rutledge, Jun Kong, Jingjing Gao, et al.
Journal of Neuropathology and Experimental Neurology|January 24, 2023
The status of digital pathology and associated infrastructure within Alzheimer's Disease CentersRebeca Scalco, Yamah Hamsafar, Charles L White, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 4, 2014
Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseasesSandeep Chhabra, Shih Chieh Chang, Hai M Nguyen, et al.
Pageof 50